Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MEDI4736
MEDI4736
New data expected at lung-cancer conference on experimental drug combos
Medical Marketing and Media
Fri, 09/4/15 - 09:01 am
lung cancer
Opdivo
Yervoy
Bristol-Myers Squibb
tremelimumab
MEDI4736
AstraZeneca
Roche
atezolizumab
AstraZeneca and MedImmune Present Positive Immuno-Oncology Combination Data at ASCO 2015
Yahoo/Reuters
Sat, 05/30/15 - 12:17 pm
AstraZeneca
MedImmune
immuno-oncology
MEDI4736
AstraZeneca and Lilly to test new cancer drug combination
Yahoo/Reuters
Fri, 05/29/15 - 10:30 am
Eli Lilly
AstraZeneca
MEDI4736
Cyramza
anti-PD-L1
10 Important Checkpoint Inhibitor Cancer Drug Abstracts from ASCO '15
TheStreet.com
Fri, 05/15/15 - 11:05 am
ASCO
cancer
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Roche
Genentech
MPDL3280A
MEDI4736
AstraZeneca
AstraZeneca & Celgene: ‘Perplexing’
Barron's
Mon, 04/27/15 - 09:22 pm
AstraZeneca
Celgene
MEDI4736
AstraZeneca insists Celgene deal about strategy, not cash
Yahoo/Reuters
Fri, 04/24/15 - 09:24 am
AstraZeneca
Celgene
cancer immunotherapy
MEDI4736
AstraZeneca Lags in Cancer Race
Yahoo/Bloomberg
Fri, 03/20/15 - 08:22 am
AstraZeneca
MEDI4736
Bristol-Myers Squibb
AZD9291
AstraZeneca Might Outperform Merck, Bristol-Myers In Cancer Therapy Market
Bidness Etc.
Mon, 09/29/14 - 10:31 am
Merck
Bristol-Myers Squibb
AstraZeneca
MEDI4736
cancer immunotherapy
Early data promising for AstraZeneca cancer drug combination
Yahoo/Reuters
Sat, 09/27/14 - 09:35 am
Astra Zeneca
MEDI4736
lung cancer
AstraZeneca steps up push into cancer immunotherapy
Yahoo/Reuters
Thu, 07/31/14 - 09:16 am
cancer immunotherapy
AstraZeneca
MEDI4736
Cancer drug data supports advanced trials - AstraZeneca
Yahoo/Reuters
Tue, 06/3/14 - 12:24 pm
AstraZeneca
ASCO
cancer
MEDI4736
AstraZeneca’s resistance efforts rely on cancer drug advances
FT.com
Fri, 05/30/14 - 10:37 am
AstraZeneca
MEDI4736
AstraZeneca starts late-stage study of key new cancer drug
Yahoo/Reuters
Thu, 05/8/14 - 10:54 am
AstraZeneca
anti-PD-L1
MEDI4736
non-small cell lung cancer